End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
121.9 BDT | -2.17% | +2.96% | -16.62% |
Sales 2024 * | 44.51B 380M 521M | Sales 2025 * | 50.42B 431M 590M | Capitalization | 54.38B 465M 636M |
---|---|---|---|---|---|
Net income 2024 * | 5.25B 44.89M 61.42M | Net income 2025 * | 6.24B 53.37M 73.03M | EV / Sales 2024 * | 1.36 x |
Net Debt 2024 * | 5.96B 50.91M 69.66M | Net Debt 2025 * | 878M 7.51M 10.27M | EV / Sales 2025 * | 1.1 x |
P/E ratio 2024 * |
9.91
x | P/E ratio 2025 * |
8.08
x | Employees | 5,700 |
Yield 2024 * |
3.41% | Yield 2025 * |
4.31% | Free-Float | 76.68% |
1 day | -2.17% | ||
1 week | +2.96% | ||
Current month | +2.44% | ||
1 month | +1.92% | ||
3 months | -13.05% | ||
6 months | -16.62% | ||
Current year | -16.62% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 61 | 89-12-31 | |
Chief Tech/Sci/R&D Officer | - | - | |
Selina Akter
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 75-12-31 | |
Founder | - | 75-12-31 | |
Iqbal Ahmed
CEO | Chief Executive Officer | - | 84-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 121.9 | -2.17% | 159,671 |
24-05-08 | 124.6 | -0.16% | 97,297 |
24-05-07 | 124.8 | -1.96% | 415,991 |
24-05-06 | 127.3 | +2.33% | 273,497 |
24-05-05 | 124.4 | +5.07% | 329,791 |
End-of-day quote Dhaka S.E., May 08, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.62% | 495M | |
+30.38% | 695B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 330B | |
+3.73% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+7.68% | 168B |
- Stock Market
- Equities
- BXPHARMA Stock